The process of embryogenesis begins when an egg or ovum is fertilized by a sperm cell to form a zygote. This zygote then undergoes mitotic division, a process that does not result in any significant ...

Medicare reimbursement issues expected for certain of Organogenesis' skin substitute projects disrupting revenues in 2025. Major catalyst is expected for ORGO with BLA filing in late 2025. Liquidity ...

Medicare's decision to slash the cost of wound-care products is shoving the regenerative medicine company Organogenesis toward a major restructuring, with the CEO conceding to staffers that "heart ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of ...

In response to inhaled pathogens, lymphoid tissues can form in the lung. The driving force behind this organogenic process turns out to be interleukin 17–mediated activation of lung stromal cells.

Therapy comprises allogeneic cells to promote regeneration of soft tissue. FDA approved Organogenesis’ cell product Gintuit™ (allogeneic cultured keratinocytes and fibroblasts in bovine collagen) for ...